Global Nuclear Imaging Market 2017-2021

SKU ID :TNV-10986482 | Published Date: 09-Aug-2017 | No. of pages: 117
Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Five forces analysis PART 06: Market segmentation by application • Oncology • Cardiology • Neurology • Others PART 07: Market segmentation by product • Standalone PET nuclear imaging • Standalone SPECT nuclear imaging • Hybrid nuclear imaging PART 08: Market segmentation by end-user • Hospitals • Diagnostic centers • Research centers PART 09: Geographical segmentation • Nuclear imaging market in Americas • Nuclear imaging market in EMEA • Nuclear imaging market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Market challenges PART 12: Market trends • Emergence of time of flight (TOF) nuclear imaging systems • Growing focus on developing PET/MRI hybrid imaging systems • Vendors' focus on emerging economies • Growing focus on cyclotron-based production • Advances in radionanomedicine PART 13: Vendor landscape • Competitive scenario • Key news PART 14: Key vendor analysis • Digirad • GE Healthcare • Mediso • Koninklijke Philips • Siemens Healthcare • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Global nuclear imaging market 2016-2021 ($ millions) Exhibit 02: Five forces analysis Exhibit 03: Global nuclear imaging market by application 2016 (%) Exhibit 04: Global nuclear imaging market by product 2016 ($ millions) Exhibit 05: Global nuclear imaging market by product 2016-2021 ($ millions) Exhibit 06: Global nuclear imaging market by product 2016-2021 (%) Exhibit 07: Global nuclear imaging market by product 2016 and 2021 (%) Exhibit 08: Global nuclear imaging market by product 2016 and 2021 ($ millions) Exhibit 09: Global nuclear imaging market by product 2016 (%) Exhibit 10: Nuclear imaging market by product type 2016 Exhibit 11: Snapshot of global PET nuclear imaging market 2016 Exhibit 12: Global standalone PET nuclear imaging market 2016-2021 ($ millions) Exhibit 13: Snapshot of global SPECT nuclear imaging market 2016 Exhibit 14: Global standalone SPECT nuclear imaging market 2016-2021 ($ millions) Exhibit 15: Snapshot of global hybrid nuclear imaging market 2016 Exhibit 16: Global hybrid nuclear imaging market 2016-2021 ($ millions) Exhibit 17: Global nuclear imaging market by end-users 2016 (%) Exhibit 18: Global nuclear imaging market by geography 2016 Exhibit 19: Global nuclear imaging market by geography 2016-2021 ($ millions) Exhibit 20: Global nuclear imaging market by geography 2016-2021 (%) Exhibit 21: Global nuclear imaging market by geography 2016 and 2021 ($ millions) Exhibit 22: Global nuclear imaging market by geography 2016 and 2021 (%) Exhibit 23: Nuclear imaging market in Americas 2016-2021 ($ millions) Exhibit 24: Nuclear imaging market in EMEA 2016-2021 ($ millions) Exhibit 25: Nuclear imaging market in APAC 2016-2021 ($ millions) Exhibit 26: Advantages of cyclotron-based radioisotopes production Exhibit 27: Competitive structure analysis of global nuclear imaging market 2016 Exhibit 28: Digirad: Key highlights Exhibit 29: Digirad: Strength assessment Exhibit 30: Digirad: Strategy assessment Exhibit 31: Digirad: Opportunity assessment Exhibit 32: GE Healthcare: Key highlights Exhibit 33: GE Healthcare strength assessment Exhibit 34: GE Healthcare strategy assessment Exhibit 35: GE Healthcare opportunity assessment Exhibit 36: Mediso: Key highlights Exhibit 37: Mediso: Strength assessment Exhibit 38: Mediso: Strategy assessment Exhibit 39: Mediso: Opportunity assessment Exhibit 40: Koninklijke Philips: Key highlights Exhibit 41: Koninklijke Philips: Strength assessment Exhibit 42: Koninklijke Philips: Strategy assessment Exhibit 43: Koninklijke Philips: Opportunity assessment Exhibit 44: Siemens Healthcare: Key highlights Exhibit 45: Siemens Healthcare: Strength assessment Exhibit 46: Siemens Healthcare: Strategy assessment Exhibit 47: Siemens Healthcare: Opportunity assessment  
GE Healthcare, Siemens Healthcare, and Koninklijke Philips, Digirad, Mediso Medical Imaging Systems, Advanced Accelerator Applications, Agfa-Gevaert, BC Technical, CardiArc, Cardinal Health, Carestream Health, CMR Naviscan, Cubresa, DDD-Diagnostic, Eczacibasi-Monrol Nuclear Products, FMI Medical Systems, FUJIFILM Holdings, MiE America, MILabs, NeuroLogica, Neusoft Medical Systems, Photo Diagnostic Systems, RadioMedix, Sofie Biosciences, Spectrum Dynamics Medical, SynchroPET, and Toshiba Medical Systems.
  • PRICE
  • $2500
    $4000

Our Clients